NDC 70771-1355-01 - CARBIDOPA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70771-1355
- Requested NDC
- 70771-1355-01
- Package NDCs from labels
- 70771-1355-1, 70771-1355-01
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2024-11-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CARBIDOPA - Zydus Lifesciences Limited | Zydus Lifesciences Limited | 2024-11-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1355-1 | CARBIDOPA | 100 in 1 BOTTLE | TABLET | 100 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1355 | CARBIDOPA TABLET [ZYDUS LIFESCIENCES LIMITED] | 7 | Current NDC, Legacy NDC, 1 package rows | 20241130_83012ccc-aba2-45bb-9326-dc30cdeb4e3b.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| carbidopa, levodopa and entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Alembic Pharmaceuticals Inc. | 9d4e886e-edec-471d-b619-bf4828a6b7ce | 2026-03-31 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Alembic Pharmaceuticals Inc. | ac18e5fa-e2ee-4aa5-8d0f-94b63a076e66 | 2026-03-30 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Amneal Pharmaceuticals NY LLC | 0eb24333-3c11-41dd-888d-3a30d3c9d188 | 2026-03-30 | Warnings, Adverse reactions | MNX7R8C5VO |
| RYTARY | CARBIDOPA AND LEVODOPA | Amneal Pharmaceuticals LLC | 6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7 | 2026-03-26 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa, Levodopa, and Entacapone | CARBIDOPA, LEVODOPA, AND ENTACAPONE | Sandoz Inc | 9c16c0e0-3b97-486b-b7d5-579f5853e2c5 | 2026-03-19 | Warnings, Adverse reactions | MNX7R8C5VO |
| Duopa | CARBIDOPA AND LEVODOPA | AbbVie Inc. | 7066d371-dc6a-0d6f-7bed-e5dd4ee912da | 2026-03-19 | Warnings, Adverse reactions | MNX7R8C5VO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Safecor Health, LLC | 015bc056-ee86-4006-ae7c-689b95e566f4 | 2026-03-19 | Warnings, Adverse reactions | MNX7R8C5VO |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 4d3a0a92-b0de-a1ea-e063-6294a90a8508 | 2026-03-17 | Warnings | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Amazon.com Services LLC | aceb0b10-8c90-4a06-8c47-cd1a2b4676a3 | 2026-03-03 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Old East Main Co. | c38c77fd-abbf-4c87-a9c0-a0e21ed3f97d | 2026-03-02 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Chain Drug Marketing Association | 86ff4875-9007-4b7b-8f46-16cbd475d4bb | 2026-02-27 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Chain Drug Marketing Association | 6c848b98-f01c-40f2-a9aa-2af76cb370c8 | 2026-02-27 | Warnings, Adverse reactions | 1K09F3G675 |
| Levico Prunus | LEVICO PRUNUS | Uriel Pharmacy Inc. | 63db9374-8ee2-48cf-8799-454c95869808 | 2026-02-27 | Warnings | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Family Dollar Stores, Inc | 1a03331e-3676-451c-be22-9a547e8ae6e2 | 2026-02-24 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Perrigo Direct, Inc | 256bd1d4-fd50-408f-9aee-84f218bb4971 | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXIND HCL | Perrigo Direct, Inc | 54a20ec9-ab86-4410-af94-e04393e9d4b3 | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Meijer, Inc. | 6b369ef2-fd54-4931-a9eb-0fb42834c2ef | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Target Corporation | d4ee05c8-ae62-45df-8783-1ed57fa030ec | 2026-02-18 | Warnings, Adverse reactions | 1K09F3G675 |
| carbidopa, levodopa and entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Alembic Pharmaceuticals Limited | 9ff83838-b7d0-4eec-98f2-fcc85789a189 | 2026-02-17 | Warnings, Adverse reactions | MNX7R8C5VO |
| Calamine | FERRIC OXIDE RED | Topco Associates LLC | 2b32e720-ac71-4d60-bc06-e28a00f8a450 | 2026-02-13 | Warnings, Adverse reactions | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.